|
Wong, Swee Kee; Connole, Michelle; Sullivan, JoAnne S et al. (2009) A New World primate deficient in tetherin-mediated restriction of human immunodeficiency virus type 1. J Virol 83:8771-80
|
|
Huang, I-Chueh; Bosch, Berend Jan; Li, Fang et al. (2006) SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem 281:3198-203
|
|
Okinaga, Shoji; Slattery, Dubhfeasa; Humbles, Alison et al. (2003) C5L2, a nonsignaling C5A binding protein. Biochemistry 42:9406-15
|
|
Gao, Jinming; Choe, Hyeryun; Bota, Dalena et al. (2003) Sulfation of tyrosine 174 in the human C3a receptor is essential for binding of C3a anaphylatoxin. J Biol Chem 278:37902-8
|
|
Farzan, Michael; Chung, Susan; Li, Wenhui et al. (2002) Tyrosine-sulfated peptides functionally reconstitute a CCR5 variant lacking a critical amino-terminal region. J Biol Chem 277:40397-402
|
|
Farzan, Michael; Babcock, Gregory J; Vasilieva, Natalya et al. (2002) The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1 alpha association and HIV-1 entry. J Biol Chem 277:29484-9
|
|
Farzan, M; Schnitzler, C E; Vasilieva, N et al. (2001) Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor. J Exp Med 193:1059-66
|
|
Farzan, M; Vasilieva, N; Schnitzler, C E et al. (2000) A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry. J Biol Chem 275:33516-21
|
